Charming Medical Ltd
corporate_fare Company Profile
Charming Medical Ltd (NASDAQ:MCTA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 6 items for MCTA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-30, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 10/10, with 4 rated 8 or above. Recent SEC coverage for MCTA spans 20-F, 6-K, SCHEDULE 13D.
Recent high-impact activity:
- Charming Medical FY2026: Revenue Slides 23%, Stock Still Halted, Material Weaknesses Flagged
- Charming Medical dismantles dual-class shares, CEO locks up stake, and adopts U.S. governance standards
- Charming Medical Appoints Audit Expert Mei Cai to Board, Tsui Resigns
- Charming Medical Appoints Audit Committee Financial Expert as Independent Director Amidst Going Concern
- Charming Medical Discloses SEC Trading Suspension, Nasdaq Halt, and Class Action Lawsuit Following IPO
Financial Snapshot
Short Interest & Short Volume
FINRA reported short interest of 574,770 shares in MCTA as of the September 15, 2026 settlement, unchanged from the prior period.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
MCTA files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.